WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005107752) USE OF OPIOID RECEPTOR ANTAGONIST COMPOUNDS FOR THE PREVENTION AND/OR TREATMENT OF DISEASES ASSOCIATED WITH THE TARGET CALCINEURIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/107752    International Application No.:    PCT/EP2005/005176
Publication Date: 17.11.2005 International Filing Date: 12.05.2005
IPC:
A61K 31/485 (2006.01), A61P 29/00 (2006.01), A61P 1/00 (2006.01), A61P 17/00 (2006.01), A61P 17/06 (2006.01), A61P 25/28 (2006.01), A61P 37/08 (2006.01), A61P 35/00 (2006.01), A61P 9/00 (2006.01), A61P 3/10 (2006.01), A61P 3/04 (2006.01), A61P 27/06 (2006.01), A61P 9/10 (2006.01)
Applicants: ALCASYNN PHARMACEUTICALS GMBH [AT/AT]; Life Science Center, Mitterweg 24, A-6020 Innsbruck (AT) (For All Designated States Except US).
SCHMIDHAMMER, Helmut [AT/AT]; (AT) (For US Only)
Inventors: SCHMIDHAMMER, Helmut; (AT)
Agent: HAMMER, Jens; Grünecker, Kinkeldey, Stockmair & Schwanhäusser, Maximilianstrasse 58, 80538 München (DE)
Priority Data:
04011293.0 12.05.2004 EP
Title (EN) USE OF OPIOID RECEPTOR ANTAGONIST COMPOUNDS FOR THE PREVENTION AND/OR TREATMENT OF DISEASES ASSOCIATED WITH THE TARGET CALCINEURIN
(FR) UTILISATION DE COMPOSES D'ANTAGONISTES DU RECEPTEUR OPIOIDE DANS LA PREVENTION ET/OU LE TRAITEMENT DE MALADIES LIEES A LA CALCINEURINE CIBLE
Abstract: front page image
(EN)Morphinane derivatives of the formula (I) their pharmaceutically acceptable salts are provided for use as medicaments for the treatment and/or prevention of disorders associated with the target calcineurin.
(FR)L'invention concerne des dérivés de morphinane de formule (I), leurs sels acceptables pharmaceutiquement à utiliser en tant que médicaments pour le traitement et/ou la prévention de troubles liés à la calcineurine cible.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)